Jinyu Su

Jinyu Su is a Research Fellow at the Biotech Research and Innovation Centre (BRIC), University of Copenhagen, affiliated with the Porse Group led by Professor Thomas Porse. The group specializes in hematopoiesis and leukemia research within Denmark's premier biomedical research hub.

Dr. Su's work centers on epigenetic mechanisms in blood cancers, particularly the role of histone modifiers like KDM5C in acute myeloid leukemia (AML) and chromatin remodelers (SWI/SNF/NuRD) in gene regulation. Key methodologies include single-cell proteomics and transcriptional network analysis to dissect cellular heterogeneity during granulocytic differentiation.

Recent publications reveal a cohesive trajectory integrating advanced mass spectrometry with genomic approaches to uncover tumor-suppressive pathways in AML. This work bridges fundamental chromatin biology with translational cancer research, emphasizing bivalent gene regulation and RNA polymerase dynamics.

As a core member of the Porse Group at BRIC, Dr. Su collaborates extensively with hematologists and molecular biologists across Copenhagen's research ecosystem, contributing to high-impact studies in top-tier journals.